{
    "title": "Gilead's Trodelvy extends breast cancer survival by 3.2 months -study",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11191273/Gileads-Trodelvy-extends-breast-cancer-survival-3-2-months-study.html",
    "date": "2022-09-07",
    "keywords": [
        "cancer",
        "trodelvy",
        "breast",
        "drug",
        "survival",
        "trial",
        "gilead",
        "chemotherapy",
        "beasley",
        "meeting",
        "risk",
        "death",
        "company",
        "study",
        "receptor",
        "her2",
        "number",
        "analysis",
        "bill",
        "goal",
        "group",
        "month",
        "type",
        "presentation",
        "friday",
        "way",
        "phase",
        "society",
        "paris",
        "test",
        "negative",
        "therapy",
        "show",
        "antibody",
        "option",
        "head",
        "oncology",
        "game",
        "changer",
        "data",
        "release",
        "march",
        "progression",
        "june",
        "time",
        "disease",
        "difference",
        "approval",
        "hormone",
        "positiveher2",
        "bladder",
        "use",
        "label",
        "warning",
        "blood",
        "cell",
        "diarrhea",
        "wall",
        "street",
        "demand",
        "competition",
        "plc",
        "reporting",
        "deena",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}